Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy

Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy is a comprehensive book that covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia. It discusses cognitive and clinical studies, memory dysfunction, neural biomarkers, and therapeutic aspects, making it a valuable tool for clinicians, psychologists, researchers, neurologists, and caregivers.

Format: Paperback / softback
Length: 254 pages
Publication date: 15 September 2021
Publisher: Elsevier Science Publishing Co Inc

The prevalence of Alzheimer's or related dementia worldwide is staggering, with nearly 44 million individuals affected, according to the Alzheimers Disease International organization. This number is expected to double every 20 years, emphasizing the urgent need for comprehensive understanding and effective therapies. In contrast to other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy delves into the latest advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia.

The book begins by providing readers with an in-depth exploration of cognitive and clinical studies, focusing on the diverse range of memory impairments experienced by individuals with Alzheimer's and other dementias. It sheds light on the prevalence of depression, its intricate relationship with other symptoms, and the impact it has on the quality of life of those affected. Additionally, the book delves into recent research on memory dysfunction in advanced-stage Alzheimer's disease, comparing it to early-stage cases and shedding light on the underlying factors that contribute to the transition from mild cognitive impairment to a definitive Alzheimer's diagnosis.

The next section of the book explores the role of different cortical and subcortical structures in the development of various symptoms associated with Alzheimer's disease. It examines the neural biomarkers that underpin the progression and treatment of the disease, offering valuable insights into potential diagnostic and therapeutic avenues.

In the final section of the book, the focus shifts to therapeutic aspects of Alzheimer's disease. It reviews behavioral and pharmacological treatments for sleep disorders, memory problems, and depression, recognizing the importance of addressing these interconnected symptoms in the comprehensive care of dementia patients.

By providing a comprehensive and up-to-date account of the latest research and clinical developments in Alzheimer's disease, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy serves as a valuable resource for clinicians, psychologists, researchers, neurologists, and caregivers alike. It equips readers with the knowledge and tools necessary to navigate the complexities of dementia care, fostering improved patient outcomes and enhancing the overall quality of life for individuals with Alzheimer's and other forms of dementia.

Weight: 410g
Dimension: 229 x 152 (mm)
ISBN-13: 9780128213346